Oxytocin for treatment of juvenile type I diabetes mellitus - increases prodn of tyrosine and adrenalin, necessary for glycogen mobilisation

摘要

The new medicament "Oxytocin" is for the treatment of diabetes mellitus type I patients who have none or insufficient oxytocin in the blood. The presumption that the low sugar level owing to a low adrenalin level is caused by an insufficient production of tyrosine. Tyrosine production is dependent on oxytocin. Therefore administration of oxytocin will produce tyrosine and hence adrenalin. Adrenalin should then mobilise glycogen for an increase in the blood sugar level causing the secretion of insulin. USE - Oxytocin is used for the treatment of juvenile type I diabetes mellitus. The blood sugar level is thereby increased to 80 to 120 mg/100 ml so that insulin is produced for the removal of blood glucose.